Greenland Mines Secures Nasdaq Compliance, Sets Q4 Biotech Spin-Off
GRML is trading near its 52-week low of $4.37 (11% above the low) on elevated volume (2.6× avg).
Summary
Greenland Mines announced Nasdaq has approved its compliance plan, resolving prior listing deficiencies. The company also set a Q4 2026 spin-off for its biotechnology division and reshaped its board: Riad El-Dada and Dr. Shalom Hirschman step down, Jason Hawkins joins. This follows the September 1 closing of the Sarfartoq rare earth acquisition and the $20M offering priced August 27. The Nasdaq approval removes a key overhang, and the spin-off sharpens focus on rare earths. Watch for the annual shareholder meeting before year-end.
At the time of this announcement, GRML was trading at $4.84 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $15.1M. The 52-week trading range was $4.37 to $36.99. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.